Explore more publications!
Mauritius Healthcare Daily
Got News to Share?

Mauritius Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mauritius Healthcare Daily.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on February 18, 2026

Olympia Pharmaceuticals Unveils Circulate, Expanding Its Single-Dose IV Nutritional Therapy Line
Feb. 18, 2026

Olympia Pharmaceuticals Unveils Circulate, Expanding Its Single-Dose IV Nutritional Therapy Line

Indeterminate GlobeNewswire
Imprivata Patient Access Now Available in Epic Toolbox for Identity Verification in MyChart
Feb. 18, 2026

Imprivata Patient Access Now Available in Epic Toolbox for Identity Verification in MyChart

Indeterminate GlobeNewswire
As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense
Feb. 18, 2026

As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense

Indeterminate GlobeNewswire
Nationwide MDA Shamrocks Campaign Advances Independence for People Living with Rare Neuromuscular Conditions
Feb. 18, 2026

Nationwide MDA Shamrocks Campaign Advances Independence for People Living with Rare Neuromuscular Conditions

Indeterminate GlobeNewswire
MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Feb. 18, 2026

MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Indeterminate GlobeNewswire
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
Feb. 18, 2026

Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results

Indeterminate GlobeNewswire
24/7 Market News- It’s Not Synthetic, It’s Real. Kraig Labs Nears Spider Silk Breakthrough
Feb. 18, 2026

24/7 Market News- It’s Not Synthetic, It’s Real. Kraig Labs Nears Spider Silk Breakthrough

Indeterminate GlobeNewswire
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
Feb. 18, 2026

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025

Indeterminate GlobeNewswire
Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State
Feb. 18, 2026

Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State

Indeterminate GlobeNewswire
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
Feb. 18, 2026

Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors

Indeterminate GlobeNewswire
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend
Feb. 18, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend

Indeterminate GlobeNewswire
GLP-1 Usage Increases 67% While Bariatric Surgeries Decline, but Long-Term Benefits Remain Unclear
Feb. 18, 2026

GLP-1 Usage Increases 67% While Bariatric Surgeries Decline, but Long-Term Benefits Remain Unclear

Indeterminate GlobeNewswire
Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio
Feb. 18, 2026

Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio

Indeterminate GlobeNewswire
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
Feb. 18, 2026

Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)

Indeterminate GlobeNewswire
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
Feb. 18, 2026

Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution

Indeterminate GlobeNewswire
Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need
Feb. 18, 2026

Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need

Indeterminate GlobeNewswire
Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser
Feb. 18, 2026

Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser

Indeterminate GlobeNewswire
Alembic Therapeutics LLC Announces the Launch of PIVYA® (pivmecillinam)
Feb. 18, 2026

Alembic Therapeutics LLC Announces the Launch of PIVYA® (pivmecillinam)

Indeterminate GlobeNewswire
Unnatural Products Announces Licensing Agreement with Novartis to Develop Macrocyclic Peptide Therapeutics
Feb. 18, 2026

Unnatural Products Announces Licensing Agreement with Novartis to Develop Macrocyclic Peptide Therapeutics

Indeterminate GlobeNewswire
Theriva™ Biologics Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications
Feb. 18, 2026

Theriva™ Biologics Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions